Metal-catalysed tandem metathesis-hydrogenation reactions for the synthesis of carba analogues of cyclic peptides

Canadian Journal of Chemistry

Volumn 83, Issue 6-7, 2005, Pages 875-881

  Whelan, Amanda N ^a,b   Elaridi, Jomana ^a   Mulder, Roger J ^b   Robinson, Andrea J ^a   Jackson, W Roy ^a  

^a MONASH UNIVERSITY   (Australia)

^b CSIRO   (Australia)

Author keywords

Dicarba analogues of cystine containing peptides, octreotide, vapreotide, and lanreotide; Tandem ring closing metathesis and hydrogenation

Indexed keywords

CATALYSIS; HYDROGENATION; RHODIUM; RUTHENIUM; SYNTHESIS (CHEMICAL);

METAL CATALYZED SEQUENCE; RING CLOSING METATHESIS; SOMATOSTATIN; TANDEM RING CLOSING METHASIS AND HYDROGENATION;

POLYPEPTIDES;

ANGIOPEPTIN; CARBON; CYCLOPEPTIDE; CYSTINE; METAL; OCTAPEPTIDE; OCTREOTIDE; RESIN; RHODIUM; RUTHENIUM; SOMATOSTATIN DERIVATIVE; VAPREOTIDE;

ARTICLE; CATALYSIS; HYDROGENATION; PEPTIDE SYNTHESIS; RING CLOSING METATHESIS;

EID: 29244485111     PISSN: 00084042     EISSN: None     Source Type: Journal    
DOI: 10.1139/v05-100     Document Type: Article

References (37)

1. K. Shin-ya, Y. Masuoka, A. Nagai, K. Furihata, K. Nagai, K. Suzuki, Y. Hayakawa, and Y. Seto. Tetrahedron Lett. 42, 41 (2001).
2. A. Yurek-George, F. Habens, M. Brimmell, G. Packham, and A. Ganesan. J. Am. Chem. Soc. 126, 1030 (2004).
3. R. Furumai, A. Matsuyama, N. Kobashi, K.-H. Lee, N. Nishiyama, H. Nakajima, A. Tanaka, Y. Komatsu, N. Nishino, M. Yoshida, and S. Horinouchi. Cancer Res. 62, 4916 (2002).
4. P. Grieco, P. Campiglia, I. Gomez-Monterrey, T. Lama, and E. Novellino. Synlett, 14, 2216 (2003), and refs. cited therein.
5. (a) P. Campiglia, I. Gomez-Monterrey, L. Longobardo, T. Lama, E. Novellino, and P. Grieco. Tetrahedron Lett. 45, 1453 (2004), and refs. cited therein;
6. (b) X. Zhu and R.R. Schmidt. Eur. J. Org. Chem. 4069 (2003), and refs. cited therein.
7. (a) R.F. Nutt, R.G. Strachan, D.F. Veber, and F.W.J. Holly. J. Org. Chem. 45, 3078 (1980);
8. (b) K. Undheim, J. Efskind, and G. Beate Hoven. Pure Appl. Chem. 75, 279 (2003).
9. W. Bauer, U. Briner, W. Doepfner, R. Haller, R. Huguenin, P. Marbach, T.J. Petcher, and J. Pless. J. Life Sci. 31, 1133 (1982).
10. D.A. Pearson, J. Lister-James, W.J. McBride, D.M. Wilson, L.J. Martel, E.R. Civitello, I.E. Taylor, B.R. Moyer, and R.T. Dean. J. Med. Chem. 39, 1361 (1996).
11. (a) E.P. Krenning, D.J. Kwekkeboom, W.H. Bakker, W.A.P. Breeman, P.M. Kooji, H.Y. Oei, M. van Hagen, P.T.E. Postema, M. de Jong, J.C. Reubi, T.J. Visser, A.E.M. Reijs, L.J. Hofland, J.W. Koper, and S.W. Lamberts. Eur. J. Nucl. Med. 20, 716 (1993);
12. (b) W.H. Bakker, R. Albert, C. Bruns, W.A.P. Breeman, L.J. Hofland, P. Marbach, J. Pless, D. Pralet, B. Stolz, J.W. Koper, S.W.J. Lamberts, T.J. Visser, and E.P. Krenning. Life Sci. 49, 1583 (1991).
13. J.S. Lewis, M.R. Lewis, A. Srinivasan, M.A. Schmidt, J. Wang, and C.J.J. Anderson. J. Med. Chem. 42, 1341 (1999).
14. (a) T. Maina, B. Nock, A. Nikolopoulou, P. Sotiriou, G. Loudos, D. Maintas, P. Cordopatis, and E. Choitellis. Eur. J. Nucl. Med. 29, 742 (2002);
15. (b) J. Fichna and A. Janecka. Bioconjugate Chem. 14, 3 (2003).
16. (a) H. Kolan, J. Li, and M.L. Thakur. Peptide Res. 9, 144 (1996);
17. (b) J.K. Amartey. Nucl. Med. Biol. 20, 539 (1993).
18. A.N. Whelan, J. Elaridi, M. Harte, S.V. Smith, W.R. Jackson, and A.J. Robinson. Tetrahedron Lett. 45, 9545 (2004).
19. S.T. Nguyen, L.K. Johnson, R.H. Grubbs, and J.W. Ziller. J. Am. Chem. Soc. 114, 9858 (1992).
20. (a) H. Kessler and N. Schmiedeberg. Org. Lett. 4, 59 (2002);
21. (b) J.F. Reichwein, C. Versuluis, and R.M.J. Liskamp. J. Org. Chem. 65, 6187 (2000);
22. (c) T.D. Clark and M.R. Ghadiri. J. Am. Chem Soc. 117, 12 364 (1995);
23. (d) S.J. Miller and R.H. Grubbs. J. Am. Chem. Soc. 117, 5855 (1995);
24. (e) E.N. Prabhakaran, V. Rajesh, S. Dubey, and J. Iqbal. Tetrahedron Lett. 42, 339 (2001);
25. (f) H.E. Blackwell, J.D. Sadowsky, R.J. Howard, J.N. Samson, J.A. Chao, W.E. Steinmetz, D.J. O'Leary, and R.H. Grubbs. J. Org. Chem. 66, 5291 (2001).
26. J.L. Stymiest, B.F. Mitchell, S. Wong, and J.C. Vederas. Org. Lett. 5, 47 (2003).
27. E. Teoh, E.M. Campi, W.R. Jackson, and A.J. Robinson. Chem. Commun. 978 (2002).
28. H.P. Hsieh, Y.T. Wu, S.T. Chen, and K.T. Wang. Bioorg. Med. Chem. 7, 1797 (1999).
29. Intolerance of catalysts to basic functionality has been previously reported. (a) S. Kotha, N. Sreenivasachary, K. Mohanraja, and S. Durani. Bioorg. Med. Chem. Lett. 11, 1421 (2001);
30. (b) R.H. Grubbs and S. Chang. Tetrahedron, 54, 4413 (1998);
31. (c) T.M. Trnka and R.H. Grubbs. Acc. Chem. Res. 34, 18 (2001);
32. (d) M.S. Sanford, J.A. Love, and R.H. Grubbs. J. Am. Chem. Soc. 123, 6543 (2003).
33. M.R. Buchmeiser. Chem. Rev. 100, 1565 (2000).
34. R. Santini, M.C. Griffith, and M. Qi. Tetrahedron Lett. 39, 8951 (1998). Incompatible resin-solvent pairing can lead to poor reaction site availability and diminished reaction rates. Rink amide resin swells poorly in methanol, but exhibits high swell in chlorinated solvents.
35. The unit cell of octreotide reveals the flexibility of the peptide backbone and contains three individual molecules of the peptide. Only one molecule (Molecule II) possesses the rotomer conformation believed to be associated with biological activity. This molecule was modelled using Insight II with the Discover Minimization Module [computer program]. Vol. 2002. Accelerys, San Diego, Calif. 1996.
36. E. Pohl, A. Heine, and G.M. Sheldrick. Acta Crystallogr. Sect. D, D51, 48 (1995).
37. K. Wüthrich. NMR of proteins and nucleic acids. John Wiley and Sons, New York. 1986.